Related Experiment Video
Updated: Jun 10, 2025

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Inflammasome protein scaffolds the DNA damage complex during tumor development
Cheng Shen1, Abhimanu Pandey1, Daniel Enosi Tuipulotu1
1Division of Immunology and Infectious Diseases, The John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory, Australia.
Abstract:
Inflammasome sensors activate cellular signaling machineries to drive inflammation and cell death processes. Inflammasomes also control the development of certain diseases independently of canonical functions. Here, we show that the inflammasome protein NLR family CARD domain-containing protein 4 (NLRC4) attenuated the development of tumors in the Apcmin/+ mouse model. This response was independent of inflammasome signaling by NLRP3, NLRP6, NLR family apoptosis inhibitory proteins, absent in melanoma 2, apoptosis-associated speck-like protein containing a caspase recruitment domain, caspase-1 and caspase-11. NLRC4 interacted with the DNA-damage-sensing ataxia telangiectasia and Rad3-related (ATR)-ATR-interacting protein (ATRIP)-Ewing tumor-associated antigen 1 (ETAA1) complex to promote the recruitment of the checkpoint adapter protein claspin, licensing the activation of the kinase checkpoint kinase-1 (CHK1). Genotoxicity-induced activation of the NLRC4-ATR-ATRIP-ETAA1 complex drove the tumor-suppressing DNA damage response and CHK1 activation, and further attenuated the accumulation of DNA damage. These findings demonstrate a noninflammatory function of an inflammasome protein in promoting the DNA damage response and mediating protection against cancer.
Insights
The inflammasome protein NLRC4 (NLR family CARD domain-containing protein 4) suppresses tumor development by activating DNA damage response pathways, independent of its inflammatory roles. This discovery reveals a novel cancer-protective function for NLRC4.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Inflammasomes are critical signaling platforms involved in inflammation and cell death.
- Some inflammasomes exhibit functions beyond canonical inflammatory pathways.
- The role of NLRC4 in tumor development is not fully understood.
Purpose of the Study:
- To investigate the role of NLRC4 in tumor development.
- To elucidate the molecular mechanisms by which NLRC4 affects tumor suppression.
- To determine if NLRC4's tumor-suppressive function is linked to inflammasome signaling.
Main Methods:
- Utilized the Apcmin/+ mouse model for tumor development studies.
- Investigated protein-protein interactions involving NLRC4, ATR, ATRIP, and ETAA1.
- Assessed DNA damage response pathways, including CHK1 activation, following genotoxicity.
Main Results:
- NLRC4 attenuated tumor development in the Apcmin/+ mouse model.
- This tumor suppression was independent of known inflammasome signaling components.
- NLRC4 directly interacted with the ATR-ATRIP-ETAA1 complex to promote CHK1 activation and DNA damage response.
Conclusions:
- NLRC4 possesses a non-canonical, non-inflammatory function in promoting DNA damage response.
- NLRC4 acts as a tumor suppressor by enhancing DNA repair mechanisms.
- These findings highlight a novel role for inflammasome proteins in cancer protection.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cancer Cell Migration through Invadopodia
DNA Damage Can Stall the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

